Current Aids News and Events | Page 23

Current Aids News and Events, Aids News Articles.
Sort By: Most Relevant | Most Viewed
Page 23 of 25 | 1000 Results
'Get in the Hearing Loop' campaign promotes doubling functionality of hearing aids
The American Academy of Audiology on behalf of audiologists, and the Hearing Loss Association of America on behalf of people with hearing loss announce a collaborative public education campaign (2010-03-02)

American Society for Microbiology honors Paul D. Bieniasz
The 2010 American Society for Microbiology Eli Lilly and Company Research Award is being presented to Paul D. Bieniasz, Ph.D., staff investigator, Aaron Diamond AIDS Research Center, and associate professor and head, Laboratory of Retrovirology, the Rockefeller University, New York, N.Y., and investigator, Howard Hughes Medical Institute, for his work on retrovirus biology. This award recognizes fundamental research of unusual merit in microbiology or immunology by an individual on the threshold of his or her career. (2010-03-02)

Combined drug therapy to treat TB and HIV significantly improves survival
Initiating antiretroviral therapy (ART) during tuberculosis therapy significantly reduced mortality rates by 56 percent in a randomized clinical trial of 642 patients co-infected with HIV and tuberculosis. The study, which provides further impetus for the integration of TB and HIV services, lays to rest the controversy on whether co-infected patients should initiate ART during or after TB treatment. (2010-02-25)

HIV drug that protects a fetus should be avoided for 1 year after childbirth, researchers say
A new study found that while nevirapine works well to prevent mother-to-child HIV transmission, a single dose of nevirapine in infected pregnant women can trigger resistance to some forms of the AIDS-drug cocktail (antiretrovirals). This nevirapine-induced resistance fades after about 12 months and no longer hinders the cocktail, UAB researchers say. (2010-02-25)

Gene-based stem cell therapy specifically removes cell receptor that attracts HIV
UCLA AIDS Institute researchers successfully removed CCR5 -- a cell receptor to which HIV-1 binds for infection but which the human body does not need -- from human cells. Individuals who naturally lack the CCR5 receptor have been found to be essentially resistant to HIV. (2010-02-25)

AADR awards the 2010 Distinguished Scientist Award to John Greenspan
The American Association for Dental Research has announced that John Greenspan, University of California, San Francisco, is the recipient of the 2010 AADR Distinguished Scientist Award. (2010-02-19)

Increased HAART coverage associated with 50 percent drop in new HIV diagnoses among injection drug users
A comprehensive population-based study, conducted by the BC Centre for Excellence in HIV/AIDS and presented at the 17th Conference on Retroviruses and Opportunistic Infections in San Francisco, shows that expanded highly active antiretroviral therapy coverage was associated with a 50 percent decrease in new yearly HIV infections among injection drug users. (2010-02-18)

Study integrating family planning and HIV treatment funded by the Bill and Melinda Gates Foundation
UCSF has received a $1.15 million grant from the Bill & Melinda Gates Foundation to determine if integrating family planning into HIV treatment and care will increase contraceptive use and decrease unintended pregnancy among HIV-positive women. UCSF will partner with the Kenya Medical Research Institute and Ibis Reproductive Health to conduct the research. (2010-02-16)

Bone-anchored hearing aids help youth with single-sided deafness
Surgically implanted hearing aids anchored to the skull bone appear to be a durable treatment option that noticeably improves hearing among children with deafness in one ear, according to a report in the February issue of Archives of Otolaryngology -- Head & Neck Surgery, one of the JAMA/Archives journals. (2010-02-15)

8 global health agencies call for better global health data
Eight global health agencies call for a concerted global effort to collect better health data. (2010-01-25)

HIV infection prematurely ages the brain
HIV infection or the treatments used to control it are prematurely aging the brain, researchers at Washington University School of Medicine in St. Louis and the University of California, San Diego have found. Blood flow in the brains of HIV patients is reduced to levels normally seen in uninfected patients 15 to 20 years older. (2010-01-21)

PrEP treatment prevented HIV transmission in humanized mice
Systemic pre-exposure administration of antiretroviral drugs provides protection against intravenous and rectal transmission of HIV in mice with human immune systems, according to a new study published Jan. 21, 2010, in the online journal PLoS ONE. (2010-01-20)

HIV: Positive lessons from home-based care
Intensive home-based nursing in HIV/AIDS patients significantly improves self-reported knowledge of HIV, awareness of medications, and self-reported adherence to medication programmes, according to a new Cochrane Systematic Review. One home-based care trial included in the review also significantly impacted on HIV stigma, worry, and physical functioning. It did not, however, help improve depressive symptoms, mood, general health, and overall functioning. (2010-01-19)

Call for AIDS denialists to be held accountable
Despite irrefutable proof that HIV treatments have proven benefits, AIDS denialists continue to deny their value. In a paper just published online in Springer's journal AIDS and Behavior, Professor Myron Essex and Dr. Pride Chigwedere, from the Harvard School of Public Health AIDS Initiative in the US, provide additional proof that withholding HIV treatments with proven benefits led to the death of 330,000 people in South Africa as the result of AIDS denialist policies. (2010-01-18)

NIH and D.C. Department of Health team up to combat District's HIV/AIDS epidemic
Officials from NIH and the city of Washington, D.C. today announced the new D.C. Partnership for HIV/AIDS Progress, a collaborative research initiative between NIH and the D.C. Department of Health designed to decrease the rate of new HIV infections in the city, improve the health of district residents living with HIV infection, and strengthen the city's response to the HIV/AIDS epidemic. (2010-01-12)

Study finds increased presence, severity of coronary artery plaques in HIV-infected men
A Massachusetts General Hospital study has found that relatively young men with longstanding HIV infection and minimal cardiac risk factors had significantly more coronary atherosclerotic plaques -- some involving serious arterial blockage -- than did uninfected men with similar cardiovascular risk. (2010-01-07)

High antiretroviral therapy adherence associated with lower health care costs
High antiretroviral therapy adherence, which is shown to be a major predictor of HIV disease progression and survival, is now associated with lower health care costs, according to researchers at the Johns Hopkins Bloomberg School of Public Health. Researchers examined the effect of antiretroviral therapy adherence on direct health care costs and found that antiretroviral therapy improves health outcomes for people infected with HIV, saving a net overall median monthly health care cost of $85 per patient. (2010-01-06)

MSU researchers creating model of HIV care for developing nations
Expanding Michigan State University's global health outreach, a team of researchers is working in the Dominican Republic to establish a model for HIV/AIDS care that can be exported to other resource-limited countries. The team, led by Reza Nassiri, the director of MSU's Institute of International Health, is treating patients and educating doctors at the Santo Domingo HIV/AIDS clinic. (2009-12-21)

Biological catch-22 prevents induction of antibodies that block HIV
Scientists seeking to understand how to make an AIDS vaccine have found the cause of a major roadblock. It turns out that the immune system can indeed produce cells with the potential to manufacture powerful HIV-blocking antibodies -- but at the same time, the immune system works equally hard to make sure these cells are eliminated before they have a chance to mature. (2009-12-15)

Hindering HIV-1-fighting immune cells
Immune proteins called HLA molecules help to activate killer T cell responses against pathogens. But according to a study that will be published online on Dec. 14 in the Journal of Experimental Medicine, one particular group of HLA molecules cripples this activation, perhaps explaining why HIV-infected individuals who express these HLAs progress to AIDS more rapidly than others. (2009-12-14)

Research reveals further progress toward AIDS vaccine
Researchers from Thomas Jefferson University are one step closer to developing a vaccine against the AIDS disease. (2009-12-14)

UCLA researchers demonstrate that stem cells can be engineered to kill HIV
Researchers from the UCLA AIDS Institute and colleagues have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells -- a process that potentially could be used against a range of chronic viral diseases. The study provides proof-of-principle -- that is, a demonstration of feasibility -- that human stem cells can be engineered into the equivalent of a genetic vaccine. (2009-12-07)

BC Centre for Excellence in HIV/AIDS lauds US Health Organization
Dr. Julio Montaner, director, British Columbia Centre for Excellence in HIV/AIDS, and president, International AIDS Society, congratulated Dr. Nora Volkow, director of the National Institute on Drug Abuse at the National Institutes of Health, for taking a leadership role in the evaluation of the (2009-12-02)

New study released on World AIDS Day measures HIV anti-retroviral regimens' safety and efficacy
A study in the New England Journal of Medicine that was released on World AIDS Day compares two anti-retroviral regimens. (2009-12-01)

Research highlights need for national HIV strategy
The US Centers for Disease Control and Prevention estimate that well over one million people in the United States are infected with HIV/AIDS. New research from North Carolina State University shows that many of those infected are minorities and do not have health insurance, and highlights the need for a national strategy to facilitate education and prevention efforts in minority and low-income populations. (2009-11-30)

Unacculturated Hispanics in US at higher risk for HIV
Researchers surveyed 600 Hispanics recruited from Los Angeles County sexually transmitted disease clinics, community-based organizations and needle-exchange programs. They found that those with low levels of acculturation -- meaning adaptation to American culture -- had fewer HIV tests and no hepatitis C tests, were more likely to test positive for HIV, and had low levels of access to health care. (2009-11-24)

Immediate, aggressive spending on HIV/AIDS could end epidemic
Money available to treat HIV/AIDS is sufficient to end the epidemic globally, but only if we act immediately to control the spread of the disease, according to research published in BMC Public Health. This approach defies conventional thinking, which recommends gradual spending over 15-20 years. The study was based on a mathematical model developed by mathematicians and biologists, who recently earned acclaim for a study on how best to handle a planetary invasion by zombies. (2009-11-17)

No-entry zones for AIDS virus
The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs. (2009-11-12)

Brown professor to lead $6 million NIH grant to study rare brain disease
Walter Atwood, professor of medical science, will lead research efforts to determine how the JC virus, which can cause a rare brain disease known as PML, attaches to host cells. He will collaborate with research teams at Dartmouth College and the University of Tübingen in Germany. (2009-11-06)

UAB awarded $11.5 million to explore ways to test youth for HIV, link them to care
Two new grants are for leadership and coordination of the Adolescent Medicine Trials Network for HIV/AIDS Intervention (ATN), a research network in the United States and Puerto Rico working to curb the epidemic through prevention, testing and treatment for youth ages 12 to 24. Projections show at least one-half of all new HIV infections each year worldwide are in youth under age 25, says Craig Wilson, M.D., a UAB professor and ATN leader. (2009-11-05)

Federal stimulus funds support studies geared to improving HIV care and prevention
One study will look at using mobile phone text messages linked to a web-based personal health record to help HIV patients' adherence to pill-taking regimens. The other study will test the feasibility and acceptability of a Web-based strategy that seeks to reduce drug and alcohol use and accompanying HIV risk behaviors and improve antiretroviral medication adherence by HIV positive patients. (2009-11-05)

Specialists in hearing, HIV come together to study AIDS patients
Specialists in HIV and in hearing at the University of Rochester Medical Center are teaming up to measure the hearing of people with AIDS. (2009-11-03)

HIV tamed by designer 'leash'
Researchers have shown how an antiviral protein produced by the immune system, dubbed tetherin, tames HIV and other viruses by literally putting them on a leash, to prevent their escape from infected cells. The insights reported in the Oct. 30 issue of the journal Cell, a Cell Press publication, allowed the research team to design a completely artificial protein -- one that did not resemble native tetherin in its sequence at all -- that could nonetheless put a similar stop to the virus. (2009-10-29)

Strategies to reduce HIV treatment dropout rates: cost-effective and improve survival chances
In a study published this week in PLoS Medicine, Elena Losina and colleagues predict that strategies to reduce dropout rates from HIV treatment programs in resource-poor settings would substantially improve patients' chances of survival and would be cost effective. (2009-10-26)

HIV care providers applaud Congress' extension of Ryan White program
Medical providers on the front lines of HIV care applaud the US Congress for extending the Ryan White HIV/AIDS Program, helping to ensure that more than half a million low-income, uninsured, or underinsured people living with HIV/AIDS have access to lifesaving care. The HIV Medicine Association and the Ryan White Medical Providers Coalition are pleased with Congress' four-year extension of this critical safety net, and urge President Obama to quickly sign this important legislation. (2009-10-21)

Research shows treating HIV-AIDS with interleukin-2 is ineffective
An international research team has demonstrated that treating HIV-AIDS with interleukin-2 is ineffective. As a result, the researchers recommend that clinical trials on this compound be stopped. Their finding was published in the New England Journal of Medicine in an article co-authored by 14 researchers, including Dr. Jean-Pierre Routy of the Research Institute of the McGill University Health Centre. (2009-10-15)

Pitt researchers find candidates for new HIV drugs
Researchers at the University of Pittsburgh found compounds that show promise as novel drugs to treat HIV infection in the process of developing a method to assess the activity of a protein that plays an essential role in the progression to AIDS. The findings were published this week in the early, online version of ACS Chemical Biology. (2009-10-13)

NIH launches 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women
The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in pregnant women launched yesterday, and a trial to conduct the same test in HIV-infected children and youth will begin next week. The International Maternal Pediatric Adolescent AIDS Clinical Trials Group is conducting the studies, which are sponsored and funded by the National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. (2009-10-09)

CD4 cell count key predictive risk factor for both AIDS-defining and non-AIDS-defining cancers in patients with HIV
Immunodeficiency (falling CD4 cell count) increases the risk of at least seven cancers in people with HIV. As such, earlier diagnosis of HIV and earlier initiation of treatment with antiretroviral therapy could delay the onset of some cancers in HIV patients, finds research published online first and in an article in the November issue of the Lancet Oncology. (2009-10-07)

Study highlights HIV/AIDS challenge in American prison system
HIV/AIDS is up to five times more prevalent in American prisons than in the general population. Adherence to treatment programs can be strictly monitored in prison. However, once prisoners are released, medical monitoring becomes problematic. A new study by Dr. Nitika Pant Pai -- an assistant professor of medicine and a medical scientist at the Research Institute of the MUHC -- suggests the majority (76 percent) of inmates take their antiretroviral treatment intermittently once they leave prison, representing a higher risk to the general population. (2009-09-29)

Page 23 of 25 | 1000 Results
   First   Previous   Next      Last is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to